The Center for Implementation and Innovation in Health Policies (Centro de Implementación e Innovación en Políticas de Salud – CIIPS) at the IECS was created in 2020 with the purpose of making a contribution to public debate and informed decision-making regarding health policies, by means of analysis and advice to national, regional and international governments, institutions and health organizations.
CIIPS is envisioned as a bridge that links academia, users, health services and health policies, translating the results of research into a comprehensible, trustworthy and accessible language for decision-makers and the general public.
WHO ARE WE?
We are an interdisciplinary and multiprofessional team of physicians, public health specialists, political and social scientists and economists, with a major background in public service, non-governmental organizations, academic institutions and private organizations, with knowledge and expertise in the management of health programs and policies.
WHAT DO WE DO?
By means of innovative proposals for the design, implementation, monitoring and assessment of health policies, CIIPS contributes with evidence, recommendations and support to interventions and policies, in order to achieve the implementation of more accessible, equitable and sustainable health systems. To such purposes, we focus on advising national, regional or international decision-makers and health institutions, both in the public sector and social security and in the private sector.
Contact us at:
WHICH ARE OUR WORK AREAS?
Advice on health institution management. Dashboards. Quality. Patient safety and HR. Accreditation. Adoption of the progressive care model by institutions. Management of health teams and performance measurement. Funding of services according to results and conditional transfers, modalities of payment to physicians and hospitals, financial incentives, payment for performance. Health service networks. Use of telemedicine as a management, second opinion and chronic patient follow-up tool. Health Primary Care: georeferencing, allocation of population under care and empanelment. Development of devices applied to people-centered care. Local community engagement. Training of managers and health teams.
Political analysis and health decision-making in local and international contexts. Diagnosis and analysis of the health situation. Mapping of health system actors. Models of system assurance and health services. Prioritization and health benefits packages. Instruments for the analysis of health services supply and demand. Resource management. User satisfaction. Crisis management. Regulation frameworks. Response and preparedness of health systems regarding COVID-19 and other emergencies, pandemics, disasters and natural catastrophes.
Policies of effective coverage of health services. Health benefit packages. Service prioritization criteria. Benefit plans for prioritized conditions. Incentives for the improvement of health care quality.
Advice for the formulation, implementation, monitoring and assessment of health projects, programs and policies: health with gender perspective, chronic non-transmissible diseases, transmissible diseases, sexual and reproductive health, mental health, immunizations, promotion of healthy communities and environments, social factors of health.
Regulatory frameworks for the approval of new drugs and drug pricing. Procurement, purchase and logistics processes for the distribution of drug products. Strategies for the purchase of products and services, joint or consolidated purchase processes for high-price drugs and technologies. Economic analysis of drugs and technologies: economic assessment of new drugs, budget impact analysis, analysis of consumption/use of drugs and technologies. Prioritized drug formularies.
Regulatory frameworks for the approval of new drugs and drug pricing. Procurement, purchase and logistics processes for the distribution of drug products. Strategies for the purchase of products and services, joint or consolidated purchase processes for high-price drugs and technologies. Economic analysis of drugs and technologies: economic assessment of new drugs, budget impact analysis, analysis of consumption/use of drugs and technologies. Prioritized drug formularies.
